- Home
- SIF vs PRLD Comparison
SIF vs PRLD Comparison
Compare SIF & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- PRLD
- Stock Information
- Founded
- SIF 1913
- PRLD 2016
- Country
- SIF United States
- PRLD United States
- Employees
- SIF N/A
- PRLD N/A
- Industry
- SIF Office Equipment/Supplies/Services
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- SIF Industrials
- PRLD Health Care
- Exchange
- SIF Nasdaq
- PRLD Nasdaq
- Market Cap
- SIF 43.8M
- PRLD 44.0M
- IPO Year
- SIF N/A
- PRLD 2020
- Fundamental
- Price
- SIF $6.86
- PRLD $1.25
- Analyst Decision
- SIF
- PRLD Strong Buy
- Analyst Count
- SIF 0
- PRLD 3
- Target Price
- SIF N/A
- PRLD $4.00
- AVG Volume (30 Days)
- SIF 57.8K
- PRLD 219.0K
- Earning Date
- SIF 08-14-2025
- PRLD 11-05-2025
- Dividend Yield
- SIF N/A
- PRLD N/A
- EPS Growth
- SIF N/A
- PRLD N/A
- EPS
- SIF N/A
- PRLD N/A
- Revenue
- SIF $83,663,000.00
- PRLD $7,000,000.00
- Revenue This Year
- SIF N/A
- PRLD N/A
- Revenue Next Year
- SIF N/A
- PRLD N/A
- P/E Ratio
- SIF N/A
- PRLD N/A
- Revenue Growth
- SIF 35.71
- PRLD N/A
- 52 Week Low
- SIF $2.33
- PRLD $0.61
- 52 Week High
- SIF $7.88
- PRLD $5.53
- Technical
- Relative Strength Index (RSI)
- SIF 58.94
- PRLD 60.92
- Support Level
- SIF $6.77
- PRLD $1.10
- Resistance Level
- SIF $7.32
- PRLD $1.26
- Average True Range (ATR)
- SIF 0.45
- PRLD 0.15
- MACD
- SIF -0.06
- PRLD 0.00
- Stochastic Oscillator
- SIF 36.50
- PRLD 81.13
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.